pegs1, I'm losing hope that any remaining aviptadil trials will make a difference on the RLFTF stock price. So I'm not following the trials as closely as I had in the past. I see treatment for ARDS as the only short term hope for SH. Maybe ACER if they can start generating sales now that ACER 001 has been approved.
I'm still waiting for the formal release of the NIH trial results.
I'm not aware of any 'ongoing' aviptadil trial that is seeking new patients. Sorry. Have you tried reaching out directly to RLFTF for any information on ongoing trials?